No abstract available
Keywords:
diabetes mellitus; haemodialysis; kidney disease; metformin.
PubMed Disclaimer
Comment on
-
Prescribing for patients on dialysis.
Smyth B, Jones C, Saunders J.
Smyth B, et al.
Aust Prescr. 2016 Feb;39(1):21-4. doi: 10.18773/austprescr.2016.008. Epub 2016 Feb 1.
Aust Prescr. 2016.
PMID: 27041803
Free PMC article.
Review.
References
-
-
Smyth B, Jones C, Saunders J. Prescribing for patients on dialysis. Aust Prescr 2016;39:21-4. 10.18773/austprescr.2016.008
-
DOI
-
PMC
-
PubMed
-
-
Salpeter SR, Greyber E, Pasternak GA, Salpeter EE. Risk of fatal and nonfatal lactic acidosis with metformin use in type 2 diabetes mellitus. Cochrane Database Syst Rev 2010;CD002967: 10.1002/14651858.CD002967.pub3
-
DOI
-
PubMed
-
-
Rachmani R, Slavachevski I, Levi Z, Zadok B, Kedar Y, Ravid M. Metformin in patients with type 2 diabetes mellitus: reconsideration of traditional contraindications. Eur J Intern Med 2002;13:428-33. 10.1016/S0953-6205(02)00131-0
-
DOI
-
PubMed
-
-
Heaf J. Metformin in chronic kidney disease: time for a rethink. Perit Dial Int 2014;34:353-7. 10.3747/pdi.2013.00344
-
DOI
-
PMC
-
PubMed
LinkOut - more resources
Full Text Sources
Other Literature Sources